Scientists: Israel proves every developed country can subdue COVID with vaccines
Prominent scientists say the transformation of Israel from a COVID-19 hotspot to a vaccination success story underlines that any developed country can subdue the virus.Israel to Buy Millions of Pfizer COVID-19 Vaccine Doses
They estimate that a relatively small number of vaccinations are needed to take a country out of crisis mode. The moment that half of the population aged 60-plus is inoculated, authorities can expect a dramatic drop in cases and hospitals are safe from being overwhelmed, they conclude.
The claims come from authors of a detailed report, published as a peer-reviewed article in the journal Cell Reports Medicine, on just how dire a COVID situation Israel faced in the early weeks of the vaccination campaign, especially as the new, highly infectious British variant was on the rampage.
“Israel was facing a range of factors that made the situation here particularly difficult, and if it succeeded despite all of this, and we could achieve a rapid decline in cases, then any developed country can,” Prof. Dan Yamin of Tel Aviv University told The Times of Israel.
He said that most other Western countries are in a better situation as they embark, or prepare to embark, on their vaccination programs, and therefore can be particularly confident upon seeing Israel’s infection, hospitalization, and death rates hit rock bottom.
His data suggests that vaccines quickly saved “hundreds of lives” in Israel, and his statistical analysis shows that the health service was swiftly protected from meltdown as a critical mass of 60-plus received vaccines.
Israel signed a deal to buy millions of doses of COVID-19 vaccine from Pfizer Inc through 2022, Prime Minister Benjamin Netanyahu said on Monday.Israel closes down remaining COVID wards as infection drops
The new vaccinations will be suitable to protect people against different variants of the coronavirus, Netanyahu said in a statement.
He said he hopes to sign a similar deal to purchase the Moderna Inc vaccine.
“This means that very soon we will have more than enough vaccines, both for adults and children,” he said.
Late on Monday, Israel’s Walla news website reported that Israel signed a deal with Moderna as well, although officials were not immediately reachable to confirm the report.
With about 81% of citizens or residents over 16 — the age group eligible for the Pfizer/BioNTech vaccine in Israel — having received both doses, infections and hospitalizations are down sharply.
Israel on Monday closed down its two remaining coronavirus wards nearly one year after they were initially opened, as COVID-19 infection rate continues to decline.
The country began closing down its coronavirus wards some weeks ago when Israel's high-speed vaccinations campaign began to bear fruit with declining number of new COVID cases.
COVID wards at Hillel Yaffe Medical Center in Hadera and Baruch Padeh Medical Center in Tiberias had remained the only two that were still operating. Both were finally shuttered on Monday, with remaining patients being moved for treatment in the internal medicine wards.
At the peak of the pandemic, Hadera's hospital operated three dedicated COVID wards, but over the past few days there have been no more than seven patients - on average - needing treatment.
"I am pleased to announce we are closing down the last active COVID ward," the hospital director, Dr. Mickey Dudkiewicz, said. "We will now be able to allocate staff to deal with the increasing needs of our internal medicine departments, which remained understaffed because of the pandemic," he said.
"If a need arises, we will re-open the wards but hope that there will be no such need," he added.





















